Company name: Pathway Rx
Description: Provider of cannabis breeding and research services in Canada. The company’s services are primarily engaged in creating a library of strains for identifying and customizing treatments for specific medical conditions, using machine learning.
Year founded: 2016
Industry: Healthcare | Group: | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Ownership: Privately Held (no backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company was acquired by Sundial Growers (NAS: SNDL) for $87,5000 in March 13, 2019. The acquisition will help the acquirer to the exclusive rights to use Pathway Rx s intellectual property in exchange for royalties. The company will receive a contingent payout of $525000 upon the completion of future performance terms.
Number of active investors:
Profile last updated:
Last known valuation: 0.13
Last known valuation date: 13-Mar-2019